252 related articles for article (PubMed ID: 19597912)
21. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
Smilic TN; Novakovic TR; Markovic-Jovanovic SR; Smilic LLJ; Mitic JS; Radunovic ML
J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
[TBL] [Abstract][Full Text] [Related]
22. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
23. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
[TBL] [Abstract][Full Text] [Related]
24. Serum Sema3A is in a weak positive association with bone formation marker osteocalcin but not related to bone mineral densities in postmenopausal women.
Liu DM; Lu N; Zhao L; Zhang MJ; Tao B; Xuan Y; Sun LH; Zhao HY; Wang WQ; Liu JM; Ning G
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2504-9. PubMed ID: 25050899
[TBL] [Abstract][Full Text] [Related]
25. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.
Muñoz-Torres M; Reyes-García R; Mezquita-Raya P; Fernández-García D; Alonso G; Luna Jde D; Ruiz-Requena ME; Escobar-Jiménez F
Maturitas; 2009 Nov; 64(3):188-92. PubMed ID: 19819089
[TBL] [Abstract][Full Text] [Related]
26. Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group.
Ravn P; Clemmesen B; Christiansen C
Bone; 1999 Mar; 24(3):237-44. PubMed ID: 10071916
[TBL] [Abstract][Full Text] [Related]
27. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
28. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
29. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.
Kushida K; Takahashi M; Kawana K; Inoue T
J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240
[TBL] [Abstract][Full Text] [Related]
30. Role of serum FSH measurement on bone resorption in postmenopausal women.
García-Martín A; Reyes-García R; García-Castro JM; Rozas-Moreno P; Escobar-Jiménez F; Muñoz-Torres M
Endocrine; 2012 Apr; 41(2):302-8. PubMed ID: 21964645
[TBL] [Abstract][Full Text] [Related]
31. Serum leptin as a determinant of bone resorption in healthy postmenopausal women.
Roux C; Arabi A; Porcher R; Garnero P
Bone; 2003 Nov; 33(5):847-52. PubMed ID: 14623061
[TBL] [Abstract][Full Text] [Related]
32. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
[TBL] [Abstract][Full Text] [Related]
33. [Osteoporosis and arterial stiffness: study of 103 women with mild to moderate risk of cardiovascular disease].
Ageev FT; Barinova IV; Seredenina EM; Orlova IaA; Kuz'mina AE; Masenko VP; Kochetov AG
Kardiologiia; 2013; 53(6):51-8. PubMed ID: 23953046
[TBL] [Abstract][Full Text] [Related]
34. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
Iki M; Morita A; Ikeda Y; Sato Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
Osteoporos Int; 2006; 17(7):1086-95. PubMed ID: 16758145
[TBL] [Abstract][Full Text] [Related]
35. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.
Reginster JY; Henrotin Y; Christiansen C; Gamwell-Henriksen E; Bruyere ; Collette J; Christgau S
Calcif Tissue Int; 2001 Sep; 69(3):130-7. PubMed ID: 11683527
[TBL] [Abstract][Full Text] [Related]
36. Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.
Pirro M; Mannarino MR; Bianconi V; De Vuono S; Sahebkar A; Bagaglia F; Franceschini L; Scarponi AM; Mannarino E; Merriman T
Osteoporos Int; 2017 Mar; 28(3):973-981. PubMed ID: 27725998
[TBL] [Abstract][Full Text] [Related]
37. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption.
Aonuma H; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y
Tohoku J Exp Med; 2009 Jul; 218(3):201-5. PubMed ID: 19561390
[TBL] [Abstract][Full Text] [Related]
38. Higher concentration of serum C-terminal cross-linking telopeptide of type I collagen is positively related with inflammatory factors in postmenopausal women with H-type hypertension and osteoporosis.
Chen YN; Wei P; Yu Bs J
Orthop Surg; 2019 Dec; 11(6):1135-1141. PubMed ID: 31823500
[TBL] [Abstract][Full Text] [Related]
39. A hospital based study of biochemical markers of bone turnovers & bone mineral density in north Indian women.
Kumar A; Devi SG; Mittal S; Shukla DK; Sharma S
Indian J Med Res; 2013 Jan; 137(1):48-56. PubMed ID: 23481051
[TBL] [Abstract][Full Text] [Related]
40. Correlation of plasma microRNA-21 expression and bone turnover markers in postmenopausal women.
Perksanusak T; Panyakhamlerd K; Hirankarn N; Suwan A; Vasuratna A; Taechakraichana N
Climacteric; 2018 Dec; 21(6):581-585. PubMed ID: 30232913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
